XNW5004
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for XNW5004, covering 2024-11-25 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors [Phase 1, Phase 2]